It is well known that beta-catenin is involved in WNT and/or PI3K/Akt signaling pathways which regulate cancer cell migration, thereby it is considered a target for the treatment of cancer (Tang et al., 2019; Zhang et al., 2020). This evidence concerns the gene CTNNB1 and cancer.